Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




PennyOmega.com Stock Report! 8/25/09, ANAD, TOOT, DTVI, RVBD, NSPH, IFSL

Penny Omega (August 25th, 2009) Writes:

PennyOmega.com Stock Report!

PennyOmega.com Hot Stock News & Alerts!

signup3m

 

Tuesday August 25, 2009

PennyOmega.com Stock Report!

**************************************************************

ANADIGICS, Inc. (NASDAQ: ANAD) today announced that the Company’s HELP3(TM) power amplifier (PA) modules are being used by Intermec Technologies Corporation for the Wireless Wide-Area Network (WAN) Flexible Network(TM) Radio in its new CN50 mobile computer. The Intermec CN50 is the industry’s most advanced rugged mobile computer, which includes 3.75G wireless wide-area network capability that supports both voice and high-speed data exchange.

The Tootie Pie Company, Inc. (OTCBB: TOOT), a premium baker and seller of high-quality, handmade pies, is pleased to announce its pies are now being carried by the SYSCO Longview, Texas operating company. Tootie Pies are currently stocked

...

Zacks Analyst Blog Highlights: Freddie Mac, MGIC, Bank of America, Nanosphere Inc. and Lear Corporation – Press Releases

Zacks Market Commentaries (July 1st, 2009) Writes:
For Immediate Release

Chicago, IL - July 1, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Freddie Mac (FRE), MGIC (MTG), Bank of America (BAC), Nanosphere Inc. (NSPH) and Lear Corporation (LEA).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Tuesday's Analyst Blog:

Housing Prices Still Falling

The April Case/Schiller Index shows that the decline in housing prices is not over yet. The best that can be said is that the rate of decline is slowing.

As the Freddie Mac (FRE) presentation pointed out yesterday (see

...

Zacks Analyst Blog Highlights: Nanosphere, Inc., CBS Corporation, News Corporation, Corrections Corporation of America and John Bean Technology Corp. – Press Releases

Zacks Market Commentaries (May 12th, 2009) Writes:
For Immediate Release

Chicago, IL - May 12, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Nanosphere, Inc. (NSPH), CBS Corporation (CBS), News Corporation (NWS), Corrections Corporation of America (CXW) and John Bean Technology Corp. (JBT).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579.

Here are highlights from Monday's Analyst Blog:

Nanosphere Q1 Revs Disappoint

Nanosphere, Inc. (NSPH) reported financial results for the period ending March 31, 2009 following the market close on May 7, 2009. Revenue came in at $255,225, all of which was from product sales, which consisted largely

...

Nanosphere Q1 Revenue Disappoints – Analyst Blog

Zacks Market Commentaries (May 8th, 2009) Writes:
Nanosphere, Inc. (NSPH) reported financial results for the period ending March 31, 2009 following the market close on May 7, 2009. Revenue came in at $255,225, all of which was from product sales, which consisted largely of cartridge sales. There was no contribution from government grants and contracts revenue during the quarter.Product sales fell 16% from the $303,404 posted in the first quarter 2008. Sales were significantly below our forecast of $520,000 ($510,000 product sales plus $10,000 in government grants and contracts revenue) due to delays in getting the cystic fibrosis (CF) and first-generation infectious disease (RVP) assays to market. Management noted that cartridge sales remained robust with customer utilization rates increasing in the quarter, both on a year-over-year and sequential basis.EPS came in at ($0.37) in the first quarter compared to our estimate of ($0.42). EPS was negatively impacted by significantly lower-than-forecast revenue ...

Nanosphere Q1 Revs Disappoint – Analyst Blog

Zacks Market Commentaries (May 8th, 2009) Writes:
Nanosphere, Inc. (NSPH) reported financial results for the period ending March 31, 2009 following the market close on May 7, 2009. Revenue came in at $255,225, all of which was from product sales, which consisted largely of cartridge sales. There was no contribution from government grants and contracts revenue during the quarter.Product sales fell 16% from the $303,404 posted in the first quarter 2008. Sales were significantly below our forecast of $520,000 ($510,000 product sales plus $10,000 in government grants and contracts revenue) due to delays in getting the cystic fibrosis (CF) and first-generation infectious disease (RVP) assays to market. Management noted that cartridge sales remained robust with customer utilization rates increasing in the quarter, both on a year-over-year and sequential basis.EPS came in at ($0.37) in the first quarter compared to our estimate of ($0.42). EPS was negatively impacted by significantly lower-than-forecast revenue ...

Nanosphere Reports In-Line – Analyst Blog

Zacks Market Commentaries (February 27th, 2009) Writes:
Nanosphere 4th Quarter Earnings Results Nanosphere, Inc. (NSPH) reported financial results for the 4th quarter and full-year 2008 following the market close on February 26, 2009. Revenue and EPS were $312,760 and ($0.43), inline with our estimate of $308,000 and ($0.41) (Street estimate $380,000 and -$0.42).Product revenue, consisting of system rentals/sales as well as cartridge sales, accounted for all of the revenue in the quarter with government grants and contracts providing no revenue. Cartridge utilization was below the company's previous expectations due to softness in the warfarin test market, which was partially offset by higher utilization for the hypercoagulation test. The company was able to add 9 new customers during the 4th quarter, bringing its current installed base to 50 customers.Revenue and EPS for the full-year were $1.367 million and ($1.67). Product revenue of $1.021 million accounted for 75% of total revenue, with ...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.